# AAP 2022 clinical practice guideline revision on hyperbilirubinemia

Guideline · id `maternal:guideline-aap-2022-hyperbilirubinemia` · Maternal & Newborn Atlas · release `c7fb95f1d15a7d13` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, life stage: Newborn  
Browse, care area: Newborn care  

## In plain language

A clinical practice guideline revision on managing high bilirubin in newborn infants of 35 or more weeks of gestation, published in Pediatrics in 2022. This atlas lists it as a reference only and does not repeat its content.

## Technical summary

A 2022 Pediatrics article that revises a clinical practice guideline on managing hyperbilirubinemia in newborns of 35 or more weeks of gestation (the printed title is in the source record). Pediatrics 2022; DOI 10.1542/peds.2022-058859; PMID 35927462. Content from the publisher of Pediatrics is identity-only in this atlas because its terms bar use by AI systems, so nothing was read beyond bibliographic metadata and no recommendation, threshold or claim is recorded. The metadata read names the authors as individuals and the journal’s publisher, but not an issuing organisation, so no issuer or authored\_by link is recorded.

## Provenance

Content hash: 42726fb81dc0df1275b281e713b89d0491c9ef22d185d7924998c5f8a49d3e9f
Last substantive edit: 2026-10-14
Evidence last checked: Not recorded